Home > Balance Sheet > CORONA REMEDIES

CORONA REMEDIES
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Deferred Tax Assets / Liabilities ₹12 Cr₹8.30 Cr₹4.29 Cr₹-4.25 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of CORONA REMEDIES ?

The latest Deferred Tax Assets / Liabilities ratio of CORONA REMEDIES is ₹12 Cr based on Mar2026 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2026₹12 Cr
Mar2025₹8.30 Cr
Mar2024₹4.29 Cr
Mar2023₹-4.25 Cr

How is Deferred Tax Assets / Liabilities of CORONA REMEDIES Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2026 ₹12 Cr
46.51
Mar2025 ₹8.30 Cr
93.65
Mar2024 ₹4.29 Cr
Positive
Mar2023 ₹-4.25 Cr -

Compare Deferred Tax Assets / Liabilities of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹12,851.4 Cr 2.5% 2.6% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹455,634.0 Cr -2.9% -2.3% 21.8% Stock Analytics
DIVIS LABORATORIES ₹241,576.0 Cr -1.6% 9.8% 51.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹184,478.0 Cr -2.6% -2.3% 37.5% Stock Analytics
CIPLA ₹111,888.0 Cr -2.2% -6.1% -12.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,322.1 Cr -0.9% -1.8% -9.8% Stock Analytics


CORONA REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

2.5%

2.6%

NA
SENSEX

-1%

-2.6%

-4.1%


You may also like the below Video Courses